FEM ETF Analysis: Emerging Markets AlphaDEX | NASDAQ
Diversified Emerging Mkts | NASDAQ, USA | Market Cap: 756m USD | 12M Return: 26.8% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 3.33M
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The First Trust Emerging Markets AlphaDEX® Fund (FEM) is a passively managed exchange-traded fund (ETF) that seeks to track the performance of the NASDAQ Emerging Markets Index, a broad benchmark of stocks from developing-market economies. The fund commits at least 90% of its net assets to the securities held in the index, providing investors with exposure to emerging market equities through a single traded security.
Rather than simply replicating the base index, FEM applies First Trusts proprietary AlphaDEX® selection methodology, which screens and ranks stocks using a combination of fundamental growth and value factors. The goal of this approach is to isolate securities with the potential to generate positive alpha, or risk-adjusted returns in excess of traditional capitalization-weighted benchmarks. As a small-cap diversified emerging markets ETF listed in the United States, FEM offers U.S. investors a targeted vehicle for participating in the growth of developing economies while employing an enhanced index strategy.
- US dollar strength pressures emerging market equity returns
- China growth slowdown weighs on largest EM index weighting
- Fed rate cut cycle revives capital flows into emerging markets
As of July 28, 2026, the stock is trading at USD 31.07 with a total of 73,084 shares traded. Over the past week, the price has changed by +1.66%, over one month by -1.81%, over three months by -4.15% and over the past year by +26.81%.
Current recommended Stop Loss: 30.20 (which is 2.8% or 1.4 ATR below the current price).
Emerging Markets AlphaDEX has no consensus analysts rating.